NK cells cultured with K562-mbIL2 or mbIL13 feeders exhibit enhanced expression of activating receptors such as NKG2D and show increased cytotoxic activity against tumor cells compared to NK cells cultured with unmodified K562 cells. The gene discussed is KLRK1; the disease is neoplasm.